This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: TOL PCLN CSCO AFL FRX


American Electric (AEP) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $46 price target. Estimates also boosted, given the company's new rate plan in Ohio.

Aflac (AFL - Get Report) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. Company has little margin to take future credit losses.

Cisco Systems (CSCO - Get Report) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $22 price target. Expect solid near-term results and guidance.

Forest Laboratories (FRX) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $37 price target.

Hospira (HSP) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $38 price target.

Int'l Flavors & Fragrances (IFF) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $65 price target.

Interpublic (IPG) upgraded at Nomura from Neutral to Buy, Nomura said. Valuation call, based on a $13 price target.

Allscripts (MDRX) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $15 price target.

NetApp (NTAP) downgraded at Cantor from Buy to Hold, Cantor Fitzgerald said. Company can continue to struggle with enterprise demand. $38 price target. (PCLN - Get Report) downgraded at Lazard from Buy to Neutral, Lazard said. Company is facing increased competition and Europe remains slow.

PulteGroup (PHM) upgraded at JP Morgan to Overweight, JP Morgan said. $15 price target. Housing fundamentals should continue to improve over the next 18 months.

PPL Corp (PPL) upgraded at UBS to Buy from Neutral, UBS said. $31 price target. Cost savings initiative.

Select Medical (SEM) downgraded at UBS to Neutral from Buy, UBS said. $14 price target. Reducing rating following strong rally.

Salix Pharmaceuticals (SLXP) upgraded at Cantor to Buy, Cantor Fitzgerald said. $60 price target. Estimates also upped, as the company is cutting costs.

Toll Brothers (TOL - Get Report) downgraded at JP Morgan to Underweight, JP Morgan said. Valuation call, based on a $30 price target.

Trimble (TRMB) rated new Buy at Lazard. $58 price target.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
FRX $99.00 -0.77%
AFL $62.25 0.00%
CSCO $29.51 0.00%
PCLN $1,237.48 0.00%
TOL $38.31 0.00%


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs